Founded
31 Dec 1986

Address

Morningside Group
88 Jian Guo Road
Room 1706, Block C Modern City SOHO
Beijing
100022
China

Open Map

Morningside Group
22/F Hang Lung Centre
2-20 Paterson Street, Causeway Bay
Hong Kong
Hong Kong SAR China

Open Map


VCID: 4084
    Profile

    Corporate information

    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Green Biologics Ltd
    United Kingdom 4 Feb 2009
    16 May 2012
    30 Jul 2010
    31 Jul 2013
    Venture
    Active
    Beijing Gaosi Bole Education Technology Co Ltd
    China 1 Oct 2011 Series A
    Active
    Chimerix Inc
    United States 1 Feb 2011 Series F
    Cylene Pharmaceuticals Inc
    Clinical stage private company developing small molecule drugs against newly validated cancer targets.
    United States 1 May 2005
    1 Sep 2010
    Series D
    Active
    Liquidia Technologies Inc
    United States 1 Jul 2010 Series C
    ViOptix Inc
    Develops, manufactures and markets innovative proprietary products for tissue oximetry, measuring oxygen saturation levels in tissues.
    United States 1 Jan 2010
    1 Oct 2004
    Series E
    Traversa Therapeutics
    United States 1 Apr 2009
    1 Feb 2008
    Series B
    Active
    Plastic Logic Ltd
    Manufacturer of plastic electronic displays
    United Kingdom 1 Aug 2008
    1 Nov 2005
    Series E
    Initial investment. Round participant. Active
    Inimex Pharmaceuticals Inc
    Canada 1 Jun 2008 Series B
    Argos Therapeutics Inc
    United States 1 Apr 2008 Series C
    51hejia.com
    26 Jul 2007 Series B
    Initial investment. Round participant. Active
    ThingMagic Inc
    Radio frequency identification (RFID) technology company.
    United States 1 Feb 2006 Series A
    Biovex Inc
    Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease.
    United States N/A
    Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.